The Current Ratio as of December 2025 (TTM) for Dynavax Technologies Corporation (DVAX) is 6.65

According to Dynavax Technologies Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 6.65. This represents a change of -37.60% compared to the average of 10.65 of the last 4 quarters.

Dynavax Technologies Corporation (DVAX) Historical Current Ratio (quarterly & annually)

How has DVAX Current Ratio performed in the past?

The mean historical Current Ratio of Dynavax Technologies Corporation over the last ten years is 6.54. The current 6.65 Current Ratio has changed 10.07% with respect to the historical average. Over the past ten years (40 quarters), DVAX's Current Ratio was at its highest in in the June 2023 quarter at 17.78. The Current Ratio was at its lowest in in the December 2021 quarter at 1.09.

Dynavax Technologies Corporation (DVAX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Dynavax Technologies Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dynavax Technologies Corporation (DVAX) Average Current Ratio

How has DVAX Current Ratio performed in the past?

The current Current Ratio of Dynavax Technologies Corporation (DVAX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Dynavax Technologies Corporation (DVAX) Current Ratio vs. Peers

How is DVAX’s Current Ratio compared to its peers?

Dynavax Technologies Corporation’s Current Ratio is greater than Amphastar Pharmaceuticals, Inc. (3.12), greater than Collegium Pharmaceutical, Inc. (1.36), less than Beta Bionics, Inc. (10.64), greater than Pacira BioSciences, Inc. (5.26), less than Immatics N.V. (7.36), greater than Evotec SE (1.58), greater than STAAR Surgical Company (5.21), less than Enliven Therapeutics, Inc. (32.58), less than Pulse Biosciences, Inc. (12.05), greater than Harrow Health, Inc. (0.62),

Build a custom stock screener for Dynavax Technologies Corporation (DVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dynavax Technologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dynavax Technologies Corporation (DVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dynavax Technologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.